Fady Ghali

Yale New Haven Hospital — United States

Medicine · Health Sciences

12h-index467citations107works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(53), Bladder and Urothelial Cancer Treatments(36), Renal and related cancers(27), Urinary and Genital Oncology Studies(15), Multiple and Secondary Primary Cancers(14)

Publications107 total

DA-SSL: self-supervised domain adaptor to leverage foundational models in turbt histopathology slides
arXiv (Cornell University)·2025Open Access
Timeliness of completion of NCI cooperative group trials.
JCO Oncology Practice·2025
Partial Cystectomy for Muscle-Invasive Bladder Cancer
Cancers·2025· 1 citedOpen Access
Evaluating the Therapeutic Role of Lymph Node Dissection in Variant Subtype Bladder Cancer
Cancers·2025Open Access
Development and Utilization of a Novel Electronic Health Record–Based Care Pathway for Nonmuscle-Invasive Bladder Cancer
Urology Practice·2025
Publication and data sharing of completed NCI cooperative group trials.
Journal of Clinical Oncology·2025
Preoperative submaximal cardiopulmonary exercise testing and its association with early postoperative complications
BJA Open·2025Open Access
MP14-05 MODELING SURVIVAL OUTCOMES OF KEYNOTE-564 WITH STANDARD OF CARE CONTROL ARM TREATMENT: A SIMULATION STUDY
The Journal of Urology·2025
EVALUATING CLINICAL OUTCOMES AND THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PLASMACYTOID UROTHELIAL CARCINOMA: INSIGHTS FROM A COMBINED NATIONAL AND INSTITUTIONAL SERIES
Urologic Oncology Seminars and Original Investigations·2025
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer
Current Oncology Reports·2025· 7 cited
Modeling survival outcomes of KEYNOTE-564 with standard of care control arm treatment: A simulation study.
Journal of Clinical Oncology·2025
Evaluating the therapeutic role of lymph node dissection in variant histology bladder cancer.
Journal of Clinical Oncology·2025
Pilot study evaluating duplex sequencing of urinary DNA as a biomarker for recurrence in non-muscle invasive bladder cancer.
Journal of Clinical Oncology·2025
Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series
Cancers·2024· 2 citedOpen Access
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study
Clinical Genitourinary Cancer·2024· 2 cited
Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older
Frontiers in Oncology·2024· 1 citedOpen Access
Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer
Clinical Genitourinary Cancer·2024· 4 cited
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER
The Journal of Urology·2024
PD34-09 PATTERNS OF CHEMOTHERAPY USE WITH PRIMARY RADIOTHERAPY FOR LOCALIZED BLADDER CANCER
The Journal of Urology·2024
Clinical Trials and Climate Change: Doing Our Part While Pursuing Progress
European Urology Focus·2023· 3 cited
page 1 of 6Next →

Frequent Co-authors

Ithaar Derweesh(28), Margaret Meagher(22), Devin Patel(18), Aaron Bradshaw(16), Sunil Patel(11), James D. Murphy(11), Umberto Capitanio(9), Jonathan L. Wright(9), Riccardo Autorino(8), Petros Grivas(8), Ahmed Eldefrawy(7), Francesco Montorsi(7), Alessandro Antonelli(7), Andrea Minervini(7), Nathan Miller(7), Riccardo Campi(6), Bruce Montgomery(6), Juan Javier‐Desloges(6), Alessandro Larcher(5), Zachary Hamilton(5)